Environmental risks cause thousands of cancers a year in Ontario: report Five-year followup confirms success of ‘Toronto Protocol’ in cancer care Extending adjuvant aromatase inhibitor (letrozole) therapy to 10 years Improves disease-free survival, reduces incidence of contralateral breast cancer, but does not improve overall survival. Cancer patients unaware they are more optimistic than their oncologist Poorer patients less likely to survive cancer, new research indicates Standardized auxiliary labels for oral oncology drugs Focus on most significant cautions for each drug, providing more consistent information to patients. Colonoscopy trial a first University of Calgary new study on testicular cancer 'a paradigm shift' Alberta researchers looking into sleep issues for children with cancer ASA a cancer preventive Ontario cancer group aids development of promising new oncology drugs OICR investing $1.2M in development of five promising early-stage oncology drug research projects. Organ transplant patients up to 3 times more likely to die from cancer: study Results suggest recipients need regular screening to catch malignancies early. First Previous 37 38 39 40 41 Next Last
